![Frontiers | A Protracted Course of COVID19 Infection in a Metastatic Breast Cancer Patient During CDK4/6 Inhibitor Therapy Frontiers | A Protracted Course of COVID19 Infection in a Metastatic Breast Cancer Patient During CDK4/6 Inhibitor Therapy](https://www.frontiersin.org/files/Articles/551697/fonc-10-01085-HTML/image_m/fonc-10-01085-g001.jpg)
Frontiers | A Protracted Course of COVID19 Infection in a Metastatic Breast Cancer Patient During CDK4/6 Inhibitor Therapy
![Quality assurance and quality control in surgical oncology - Hardt - 2022 - Journal of Surgical Oncology - Wiley Online Library Quality assurance and quality control in surgical oncology - Hardt - 2022 - Journal of Surgical Oncology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ae8f0d05-ead3-47dd-959f-633b9728955b/jso27074-fig-0001-m.jpg)
Quality assurance and quality control in surgical oncology - Hardt - 2022 - Journal of Surgical Oncology - Wiley Online Library
![The 2018 assisi think tank meeting on breast cancer: International expert panel white paper - ScienceDirect The 2018 assisi think tank meeting on breast cancer: International expert panel white paper - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1040842820301050-ga1.jpg)
The 2018 assisi think tank meeting on breast cancer: International expert panel white paper - ScienceDirect
![ECCO 2017: Women treated for precursor of breast cancer can expect to live as long as other women - ecancer ECCO 2017: Women treated for precursor of breast cancer can expect to live as long as other women - ecancer](https://cdn.ecancer.org/6973-m.jpg)
ECCO 2017: Women treated for precursor of breast cancer can expect to live as long as other women - ecancer
![Frontiers | The Diagnostic Performance of Diffusion Kurtosis Imaging in the Characterization of Breast Tumors: A Meta-Analysis Frontiers | The Diagnostic Performance of Diffusion Kurtosis Imaging in the Characterization of Breast Tumors: A Meta-Analysis](https://www.frontiersin.org/files/Articles/575272/fonc-10-575272-HTML/image_m/fonc-10-575272-g001.jpg)
Frontiers | The Diagnostic Performance of Diffusion Kurtosis Imaging in the Characterization of Breast Tumors: A Meta-Analysis
![MammaPrint High1/High2 risk class as a pre-specified biomarker of response to nine different targeted agents plus standard neoadjuvant therapy for ~ 1000 breast cancer patients in the I-SPY 2 TRIAL (52239) MammaPrint High1/High2 risk class as a pre-specified biomarker of response to nine different targeted agents plus standard neoadjuvant therapy for ~ 1000 breast cancer patients in the I-SPY 2 TRIAL (52239)](https://d544i1zeqmmnk.cloudfront.net/i/wcm/181113_6155_ECCO_ENA_2018_Dublin/thumbn/congressresource_52239.jpg?w=300)